Reduced renal function is an established risk factor for cardiovascular events. We compared 3 measures of renal function-serum cystatin C, serum creatinine, and calculated creatinine clearance-as predictors of subsequent cardiovascular events in a community-based population of elderly individuals.
Impaired renal function is prevalent in the elderly and is associated with an increase in cardiovascular risk (1) (2) (3) . When serum creatinine was used as an index of impaired renal function in patients with existing cardiovascular disease it was found to be an independent risk factor that substantially increased morbidity and mortality (1, 4 ) . Community-based studies in elderly subjects whose only risk factor was an age Ͼ65 years confirmed serum creatinine as a significant short-term predictor of stroke (2 ) and congestive cardiac failure (3 ) .
Reduced renal function can also be assessed with creatinine-based formulae such as the Cockcroft-Gault formula (5 ) , which calculates creatinine clearance rate in mL/min, or the Modification of Diet in Renal Disease (MDRD) 5 formula, which calculates glomerular filtration rate in mL/min/1.73m 2 (6 ) . When creatinine-based formulae were applied in a large sample of communitydwelling subjects, an independent graded association was observed between reduced renal function and risks of death, cardiovascular events, and hospitalization (7 ) . Similar results were obtained in subjects whose only risk factor was an elderly age; reduced renal function was an independent risk factor for de novo cardiovascular events and all-cause mortality (8 ) .
More recently, other markers of renal function have been applied. Cystatin C, a cysteine proteinase inhibitor produced at a constant rate and freely filtered by the glomerular membrane, has been successfully used as an indicator of renal function. Some studies report that cystatin C is a potentially superior indicator of renal function than either creatinine or creatinine-based formulae (9 -11 ) . In a study of type 1 and type 2 diabetes patients, cystatin C and the Cockcroft-Gault and MDRD formulae were compared as indicators of renal function, with iodohexol clearance as a reference method; cystatin C proved to be better correlated with glomerular filtration rate (10 ) . However, the literature remains divided on the added value of cystatin C compared to creatinine (12, 13 ) for detecting early renal impairment.
Equivocal results have been reported when cystatin C or renal function formulae based on cystatin C are compared to creatinine or creatinine-based formulae as indicators of risk of cardiovascular events. In ambulatory individuals with coronary artery disease, some studies report cystatin C as a better indicator of risk of cardiovascular events and mortality than other measures of renal function (14, 15 ) . Some authors have suggested that because cystatin C is a marker of inflammation, it is also a risk factor for cardiovascular events (16, 17 ) . Specifically in the elderly age group, cystatin C proved superior to serum creatinine as a predictor of heart failure (18 ) and superior to creatinine and creatinine-based formulae as a predictor of peripheral arterial disease (19 ) .
One study reported that rapid decline of kidney function, whether estimated from creatinine or cystatin C concentrations, gave similar hazard ratios for cardiovascular or all-cause mortality, although it was acknowledged that the 2 measures had additive risk and were therefore complementary (20 ) .
In the present study, we evaluated cystatin C to see whether it offered any advantages over routinely available measures using either creatinine or creatinine clearance rate as risk indicators for cardiovascular disease and coronary heart disease. The study was a 10-year follow-up of community-dwelling subjects Ն60 years old at baseline who participated in the 1994/95 Busselton health survey.
Materials and Methods

POPULATION AND SUBJECTS
Residents of Busselton in the southwest region of the state of Western Australia participated in several crosssectional health surveys over the period 1966 -1987 . Busselton residents are Ͼ90% Caucasian and predominantly of Anglo-Celtic descent. In 1994/95, all surviving participants of earlier surveys were invited to participate in a follow-up survey. A total of 1410 subjects who attended the 1994/95 survey and were Ն60 years old provided a blood sample and had available measurements on the studied risk factors. All participants gave informed consent, and the survey was approved by the Human Research Ethics Committee of the University of Western Australia.
MEASUREMENT METHODS
The conduct of the Busselton health surveys has been described (21, 22 ) . In brief, survey participants were asked to complete a comprehensive health and lifestyle questionnaire and to undergo various measurements and tests. Blood pressure was measured by use of a mercury sphygmomanometer after 5 min rest in a sitting position.
Anthropometric measures (including waist circumference) were obtained by trained survey staff using standardized protocols. Smoking and diabetes status were obtained by questionnaire. Serum cholesterol and HDL and LDL cholesterol were determined from a fasting blood sample at the time of survey.
CYSTATIN C AND CREATININE-BASED INDICES
Serum creatinine was measured by use of an alkaline picrate method (Boehringer) on an automated Hitachi 747 analyzer using reagents on a fasting blood sample at the time of survey, 1994 -95. Cystatin C was assayed in 2007 on aliquots of collected sera stored at Ϫ70°C and thawed once only for nephelometric determination (Dade-Behring BNII).
We used the Cockcroft-Gault formula (5 ) to calculate creatinine clearance rate in mL/min from serum creatinine [in mol/L: creatinine clearance ϭ {(140 Ϫ age) ϫ weight (kg) ϫ F}/(serum creatinine ϫ 0.8136), where F ϭ 1 for males, and 0.85 for females].
DEFINITION OF CARDIOVASCULAR END POINTS
The Human Research Ethics Committee of the University of Western Australia and the Confidentiality of Health Information Committee of the Department of Health of Western Australia gave permission to access the Hospital admission and death records for participants via record linkage to the Hospital Morbidity Data System that contains linked records of all hospital admissions from public and private hospitals in Western Australia, as well as all deaths since 1980 (23 ) .
We accessed hospital admission and death records from 1980 to the end of 2004 for this study. History of cardiovascular disease (CVD) was defined as having any hospital admission with a primary or secondary CVD discharge diagnosis [International Classification of Diseases, Revision 9 (ICD-9) 390 -459] during the 15 years before the survey (i.e., from 1980 to 1994). Incident CVD events and coronary heart disease (CHD) events during the 10-year follow-up period to the end of 2004 were ascertained from hospital admission and death records for this period. Incident CHD events were defined as a hospital admission or death with principal diagnosis of CHD (ICD-9 410 -414; ICD-10 I20 -25). Incident CVD events were defined as a hospital admission with principal diagnosis of CHD, stroke (ICD-9 430 -437; ICD-10 I60 -68, G45), congestive heart failure (ICD-9 428; ICD-10 I50), or peripheral arterial disease (ICD-9 440 -448; ICD-10 I70 -79) or death from cardiovascular disease (ICD-9 390 -459; ICD-10 I00 -99, G45).
DATA ANALYSIS
Serum cystatin C and creatinine had skewed distributions that were log-transformed for use in analyses. In the descriptive results, cystatin C and creatinine data are presented as geometric mean and interquartile range (IQR) instead of mean and SD (Table 1) . We calculated correlations between measures of renal function as Pearson correlation coefficients and used Cox regression models for time from baseline to CVD/ CHD event to obtain the age-and sex-adjusted and multivariate adjusted hazard ratios (and their 95% CIs) for these incident events in relation to the different measures of renal function (Tables 2 and 3 ). The hazard ratios for continuous measures are expressed in terms of the relative increase in risk associated with a 1-SD deterioration in the measure (i.e., increase for cystatin C and creatinine and decrease for creatinine clearance). Table 1 describes baseline characteristics of the study cohort by sex and overall, including data on several a The hazard ratio is the relative increase in risk associated with a 1-SD deterioration in the measure; for creatinine clearance, 18.7 mL/min for men, 17.0 mL/min for women, and 18.4 mL/min for the overall cohort. Changes of 1 SD for log cystatin C were 0.25 mg/L for men, 0.26 mg/L for women, and 0.26 mg/L for the overall cohort, and for log creatinine, 21 mol/L for men, 17 mol/L for women, and 23 mol/L for the overall cohort. The P value is the significance for all.
Results
standard risk factors such as systolic blood pressure, HDL cholesterol, and the proportion with diabetes. The 3 measures of renal function were correlated with each other as follows: cystatin C (log-transformed) was strongly correlated with log(creatinine) in men and women (correlation coefficients 0.76 and 0.65, respectively) and moderately correlated with creatinine clearance in men and women (correlation coefficients Ϫ0.57 and Ϫ0.40, respectively). Table 2 shows the age-and sex-adjusted hazard ratios (i.e., relative risk) for each measure of renal function over the 10-year follow-up period in relation to a total of 254 incident CHD and 453 incident CVD events. The hazard ratios for continuous measures are expressed in terms of the relative increase in risk associated with a 1-SD deterioration in the measure (i.e., increase for cystatin C and creatinine and decrease for creatinine clearance). Using SD change overcomes the problem of different scales or units for each measure and allows relative risks to be directly compared to ascertain which measure has the greatest effect on risk. For creatinine clearance, the hazard ratio is the relative increase in risk associated with a 1-SD deterioration in the measure, 18.4 mL/min for the overall cohort. A 1-SD change in log(cystatin C) and log(creatinine) represent a change of approximately 1 IQR in their untransformed values, 0.26 mg/L and 23 mol/L, respectively, for the overall cohort. The complete set of SDs and IQRs values are provided in Table 1 .
Cystatin C, creatinine, and creatinine clearance were all significantly associated with CHD and CVD, with the exception of creatinine clearance in women. In the overall population, the age-and sex-adjusted hazard ratios for CVD were 1.32, 1.22, and 1.29 for cystatin C, creatinine, and creatinine clearance, respectively, with overlap in their individual CIs (Table 2) . Table 3 shows the same relative risk estimates as Table 2 after further multivariate adjustment for established cardiovascular risk factors including age, sex, diabetes, history of CVD, smoking, systolic blood pressure, LDL and HDL cholesterol, and waist circumference. Only the hazard ratios for creatinine clearance in men and creatinine clearance in the overall population retained a significant association with CHD. For CVD, however, hazard ratios for cystatin C and creatinine clearance retained significant associations for men and women separately and overall, and creatinine remained significant only in men and for the overall population.
Therefore, additional adjustment for all cardiovascular risk factors attenuated the association of all measures of renal function, particularly with incident CHD, but also with CVD (Table 3 ). In both men and women and overall, creatinine clearance had the largest relative risk estimate compared with the other measures of renal function, but there was considerable overlap in their CIs. In multivariate models, for both CHD and CVD in men and women, cystatin C was not significant (P Ͼ 0.05) after adjustment for creatinine clearance.
Discussion
We studied cystatin C, creatinine, and creatinine clearance as possible predictors of risk of morbidity and mortality from CHD and CVD events in a 10-year follow-up of community-dwelling elderly adults who were Ն60 years old at baseline. The age-and sexadjusted hazard ratios indicated that serum creatinine, creatinine clearance, and serum cystatin C were all significant predictors of incident CHD and CVD events, and there was no evidence for cystatin C as a stronger risk predictor. Furthermore, after adjustment of the hazard ratios for established cardiovascular risk factors, the relative risk estimates were approximately equally reduced for the 3 measures of renal function. Several studies have specifically examined the association of these indices of renal function with cardiovascular outcomes in community-dwelling elderly subjects. Shlipak et al. (24 ) followed 4637 elderly communitydwelling individuals and measured serum creatinine and cystatin C at baseline. Higher cystatin C concentrations were significantly associated with risk of cardiovascularrelated death, myocardial infarction, and stroke, whereas creatinine was not independently associated with any of these outcomes. Similar results were obtained for a follow-up of 3075 ambulatory elderly subjects; cystatin C but not creatinine concentrations were significantly associated with increased mortality (25 ) . An important difference with the present study was the inclusion of risk of all-cause mortality as an endpoint for the elderly subjects studied by Shlipak et al. (24, 25 ) . Sarnak et al. (18 ) and O'Hare et al. (19 ) also reported significant associations with cystatin C but not creatinine concentrations in their studies of elderly subjects. By contrast, the present similar community-based study of elderly subjects finds that cystatin C was no better than creatinine or creatinine clearance as a predictor for incident CHD or CVD. However there are some differences in endpoints chosen for these studies; Sarnak et al. (18 ) used incident heart failure, and O'Hare et al. (19 ) used the first of either bypass surgery, angioplasty, or amputation as endpoints, whereas the present study assessed CHD and CVD events.
Creatinine measurement is inexpensive and widely available, but age, sex, weight, and race affect creatinine production, occasionally making it misleading with respect to predicting renal function (16 ) . In the elderly, creatinine production decreases and may be further reduced where renal function is declining rapidly due to poor diet or lack of physical activity. Estimating the creatinine clearance with the Cockcroft-Gault formula is an improvement but suffers from overestimation of the glomerular filtration rate, as tubular secretion becomes more important where the glomerular filtration rate is either already low or declining. Froissart et al. (26 ) have pointed out the Cockcroft-Gault formula is least accurate in subjects with compromised glomerular filtration rates of Ͻ60 mL/min/1.73m 2 , and its performance also varies in different population subgroups-for example, it is less precise in obese subjects.
The Cockcroft-Gault formula is also adversely affected by the variation seen in commonly available serum creatinine assays (16 ) . It should also be noted that creatinine-based formulae can themselves be variable and yield uncertain estimates of the true glomerular filtration rate (27, 28 ) . In the present study, however, we are concerned with these estimates as predictors of the risk of CHD and CVD events rather than predictors of renal function.
Cystatin C appears to offer several advantages for the assessment of renal function in the elderly, including a constant rate of production compared with creatinine and creatinine-based indices. Early enthusiasm has been tempered by the realization that diverse factors including age, weight, smoking, and inflammation are likely to affect cystatin C concentrations (29 ) . Because cystatin C is also a marker of inflammation, there is some evidence that it may predict adverse outcomes independently of renal function, particularly in patients with prevalent coronary artery disease (15, 17, 30 ) .
In a longitudinal study of the rate of decline in renal function in community-dwelling elderly, serum creatinine and cystatin C were assessed at baseline, year 3, and year 7 of follow-up (20 ) . Although the proportion of individuals suffering rapid renal function decline assessed by cystatin C was greater than for creatinine, both indices were associated with a similarly increased risk of cardiovascular and all-cause death. The highest risk applied in subjects where the rapid decline in renal function was detected by both measures. In discussing their findings, the authors noted that cystatin C and creatinine captured overlapping subgroups and therefore provided complementary risk assessment. In the present study, however, we found that cystatin C did not add to the prediction for CHD or CVD after adjustment for creatinine clearance.
Participants in this study are not randomly selected residents; they are survivors who had attended earlier studies, who were Ն60 years old, and who were then invited to participate. This may have introduced bias in that participants may not display the same risk factors as the community population taken as a whole. Similarly, their status as survivors may place our participants in a different, possibly higher, socioeconomic status, and as a result they may have different risk factors for incident CHD or CVD than the community as a whole.
In conclusion, cystatin C is equivalent to routine measures of renal function in relation to prediction of future risk of CHD or CVD events in our elderly community-based population, and there was no evidence that it added to risk prediction beyond the other measures. Creatinine estimations are routinely available on all general chemistry analyzers, whereas cystatin C may not be available in all pathology laboratories. From this study, there is no evidence to support the routine measurement of serum cystatin C over creatinine. 
